AU2002211566A1 - Method for identifying increased risk of death from community acquired pneumonia - Google Patents
Method for identifying increased risk of death from community acquired pneumoniaInfo
- Publication number
- AU2002211566A1 AU2002211566A1 AU2002211566A AU1156602A AU2002211566A1 AU 2002211566 A1 AU2002211566 A1 AU 2002211566A1 AU 2002211566 A AU2002211566 A AU 2002211566A AU 1156602 A AU1156602 A AU 1156602A AU 2002211566 A1 AU2002211566 A1 AU 2002211566A1
- Authority
- AU
- Australia
- Prior art keywords
- death
- increased risk
- acquired pneumonia
- community acquired
- identifying increased
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010035664 Pneumonia Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23913300P | 2000-10-10 | 2000-10-10 | |
US60239133 | 2000-10-10 | ||
PCT/US2001/031577 WO2002031197A1 (en) | 2000-10-10 | 2001-10-10 | Method for identifying increased risk of death from community acquired pneumonia |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002211566A1 true AU2002211566A1 (en) | 2002-04-22 |
Family
ID=22900752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002211566A Abandoned AU2002211566A1 (en) | 2000-10-10 | 2001-10-10 | Method for identifying increased risk of death from community acquired pneumonia |
Country Status (3)
Country | Link |
---|---|
US (1) | US6866999B2 (en) |
AU (1) | AU2002211566A1 (en) |
WO (1) | WO2002031197A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112485448B (en) * | 2020-11-20 | 2021-08-24 | 浙江大学 | Application of NMI protein as biological target in preparation of adult community acquired pneumonia severity and prognosis evaluation kit |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200313A (en) * | 1983-08-05 | 1993-04-06 | Miles Inc. | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies |
DK171161B1 (en) | 1985-03-28 | 1996-07-08 | Hoffmann La Roche | A method for detecting the presence or absence of at least one specific nucleic acid sequence in a sample or for distinguishing two different nucleic acid sequences in this sample |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
WO1998035012A2 (en) * | 1997-02-12 | 1998-08-13 | Chan Eugene Y | Methods and products for analyzing polymers |
IL145714A0 (en) * | 1999-04-02 | 2002-07-25 | Interleukin Genetics Inc | Prediction of risk of interstitial lung disease |
WO2002031194A1 (en) * | 2000-10-10 | 2002-04-18 | Genomics Collaborative, Inc. | METHOD OF DIAGNOSING AND TREATING INCREASED RISK OF DEATH FROM COMMUNITY-ACQUIRED PNEUMONIA ASSOCIATED WITH THE A ALLELE OF THE TNFα-238 POLYMORPHISM |
-
2001
- 2001-10-10 US US09/973,850 patent/US6866999B2/en not_active Expired - Fee Related
- 2001-10-10 WO PCT/US2001/031577 patent/WO2002031197A1/en active Application Filing
- 2001-10-10 AU AU2002211566A patent/AU2002211566A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002031197A1 (en) | 2002-04-18 |
US20020086016A1 (en) | 2002-07-04 |
US6866999B2 (en) | 2005-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001234608A1 (en) | Methods for analysis of gene expression | |
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AU2002303584A1 (en) | Method for identifying comparable instruments | |
AU4005900A (en) | Method for identification of unknown substances | |
AU2001290685A1 (en) | Methods for inhibiting inflammatory disease | |
AU2002302243A1 (en) | Method for determination of co-occurences of attributes | |
AU2002247183A1 (en) | Removal of acids from oils | |
AU2002216080A1 (en) | Method for determining competing risks | |
AU2001271841A1 (en) | Methods for identifying combinations of drugs | |
AU2001232354A1 (en) | Method for managing physical distribution of merchandise | |
AU2002361357A1 (en) | Method for monosulphonylation of an aminobenzofuran compound | |
AU2000248557A1 (en) | Method of removing microbial contamination | |
EP1275633A3 (en) | Method for decomposition of Michael type adduct | |
AU2002222618A1 (en) | Method of analyzing gene expression | |
AU2001278135A1 (en) | Method of identifying immunosuppressive agents | |
AU2001287268A1 (en) | Method of identifying inhibitors of tie-2 | |
AU2001213451A1 (en) | Method for preparation of polycarbonates | |
AU2002211566A1 (en) | Method for identifying increased risk of death from community acquired pneumonia | |
AU2002214954A1 (en) | Process for the preparation of phenylphenol compounds | |
AU4151800A (en) | Method for extracting business rules | |
AU2001258718A1 (en) | An improved process for the preparation of quinolone derivatives | |
AU2002210816A1 (en) | Process for preparation of beta-phenethylamine derivative | |
AU2002220757A1 (en) | Method for obtaining azaerythromycin | |
AU2002351532A1 (en) | Method of sampling | |
AU2001246862A1 (en) | Method of detecting cancer |